Developing Innovative Therapies for Undertreated Conditions
Relypsa is a biopharmaceutical company focused on the development and commercialization of late-stage medicines in the iron deficiency, nephrology and cardio-renal therapeutic areas. We are committed to delivering innovative therapies that will change treatment paradigms and improve patients’ lives.
Relypsa has a rich legacy in polymer technology and is headquartered in Redwood City, Calif. Relypsa was founded in 2007 and, in September 2016, became a Vifor Pharma Group company. Today, we have nearly 400 employees united by a passion for improving patients’ lives.
Learn more about Vifor Pharma here.
Part of our work at Relypsa involves supporting the communities who benefit from our medicines. We support a variety of organizations including the American Association of Kidney Patients (AAKP), the American Kidney Fund (AKF) and the National Kidney Foundation (NKF).